(A) Renal function status at 90 days following the onset of AKI (n = 634) | (B) Eligibility and number of subjects assessed for each long-term outcome (see statistical analyses section) | |||
---|---|---|---|---|
Post-90d-eGFR-based renal function status | n | Assessment of long-term outcomes | Eligible patients | n |
(I) Preserved eGFR | 187 (29.5%) | Stage 3 CKD | post-90d-eGFR ≥ 60 mL/min/1.73 m2 | 187 (I) |
(II) Stage 3 CKD | 187 (29.5%) | Stage 4 CKD | post-90d-eGFR ≥ 30 mL/min/1.73 m2 | 374 (I+II) |
(III) Stage 4 CKD | 47 (7.4%) | Stage 5 CKD | post-90d-eGFR ≥ 15 mL/min/1.73 m2 | 421 (I+II+III) |
(IV) Stage 5 CKD | 10 (1.6%) | ESRD | all hospital survivors | 634 (I+II+III+IV+V+VI) |
(V) Unknown | 160 (25.2%) | Mortality | all hospital survivors | 634 (I+II+III+IV+V+VI) |
(VI) Death before 90 days | 43 (6.8%) | Â | Â | Â |